FEMARA 2.5
96.62 AUD
Femara 2.5 is a prescription medication containing the active ingredient Letrozole, which belongs to a class of drugs known as aromatase inhibitors. It is primarily used to treat certain types of breast cancer in postmenopausal women by blocking the production of estrogen. Femara 2.5 may also be used off-label for other medical purposes as determined by a healthcare provider.
Femara 2.5 is a prescription medication that contains the active ingredient Letrozole. It is a potent aromatase inhibitor used to treat certain types of breast cancer in postmenopausal women. Letrozole works by blocking the production of estrogen, a hormone that promotes the growth of breast cancer cells.
Femara 2.5 is used to treat breast cancer in women who have already gone through menopause. It is prescribed for the treatment of hormone receptor-positive breast cancer, which is a type of cancer that grows in response to estrogen. This medication is often used after surgery, radiation therapy, and other treatments have been tried and failed.
Femara 2.5 is taken orally, once a day, with or without food. The dosage is determined by the healthcare provider based on the patient’s medical history, response to treatment, and other factors. It is important to follow the dosing instructions carefully and not to stop taking the medication without consulting a healthcare provider.
Side effects of Femara 2.5 may include hot flashes, fatigue, nausea, vomiting, headache, dizziness, muscle or joint pain, and increased sweating. Some patients may also experience more serious side effects, such as bone fractures, high cholesterol, liver problems, and an increased risk of developing blood clots.
It is important to inform the healthcare provider of any other medications or supplements the patient is taking, as some may interact with Femara 2.5. This medication should not be taken during pregnancy, as it may harm the developing fetus.
In general, Femara 2.5 is a prescription medication containing Letrozole, which is used to treat certain types of breast cancer in postmenopausal women. It works by blocking the production of estrogen, a hormone that promotes the growth of breast cancer cells. It is important to follow the dosing instructions carefully and report any side effects to the healthcare provider. Femara 2.5 should only be used for its approved medical purposes and under the supervision of a healthcare provider.
| Brand | |
|---|---|
| Package | 30 tabs (2,5 mg/tab) |
| Substance |
More products
-
FEMARA 2.5
96.62 AUDAdd to cartFemara 2.5 is a prescription medication containing the active ingredient Letrozole, which belongs to a class of drugs known as aromatase inhibitors. It is primarily used to treat certain types of breast cancer in postmenopausal women by blocking the production of estrogen. Femara 2.5 may also be used off-label for other medical purposes as determined by a healthcare provider.
-
Fempro
13.57 AUDAdd to cartFempro is a medication used as an anti-estrogen to treat certain types of breast cancer in women. It works by reducing the amount of estrogen produced by the body, which can slow or stop the growth of cancer cells.
-
Letromina
75.48 AUDAdd to cartLetromina is a powerful anti-estrogen medication designed to help athletes and bodybuilders combat estrogen-related side effects such as water retention and gynecomastia. Its active ingredient, letrozole, works by inhibiting the aromatase enzyme, which is responsible for converting androgens into estrogens in the body.
-
Letros 2.5
107.19 AUDRead moreLetros 2.5 is an anti-estrogen medication that is designed to prevent the conversion of testosterone to estrogen in the body. It is commonly used by bodybuilders and athletes to combat estrogen-related side effects such as water retention, gynecomastia, and acne. Letros 2.5 is a highly effective and potent medication that can help users achieve their desired physique without the negative effects of excess estrogen.
